2:49 PM
Oct 23, 2018
 |  BC Extra  |  Company News

Pfizer neuroscience spinout Cerevel launches with $350M from Bain

Less than a year after terminating its neuroscience program, Pfizer Inc. (NYSE:PFE) spun out Cerevel Therapeutics LLC with $350 million in funding from Bain Capital. The pharma will have a 25% stake in Cerevel, which will be based in the Greater...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >